7 Hills Pharma Inc. — Form D
7 Hills Pharma Inc. of HOUSTON, TX, a company, filed a Form D exempt-offering notice with the SEC on 2024-07-17. The offering totals $5.0M, of which $1.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2024-07-17
- Form: D
- Accession: 0002030700-24-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $1.0M
- Remaining: $4.0M
- Minimum investment: $250K
- Investors: 1
- Date of first sale: 2024-05-09
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-519029
Issuer
- Name: 7 Hills Pharma Inc.
- CIK: 0002030700
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 2450 HOLCOMBE BLVD., SUITE J., HOUSTON, TX, 77021-2041
- Phone: 8324396612
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Joseph Bailes | Director | Houston, TX |
| Stephen A Bent | Director | Houston, TX |
| Kala Marathi | Director | Houston, TX |
| Upendra Marathi | Director | Houston, TX |
| Robert A Bent | Executive Officer | Houston, TX |
| Stephen A Bent | Executive Officer | Houston, TX |
| Upendra Marathi | Executive Officer | Houston, TX |
More